MicroRNA-20a-5p Downregulation by Atorvastatin: A Potential Mechanism Involved in Lipid-Lowering Therapy

MicroRNA-20a-5p Downregulation by Atorvastatin: A Potential Mechanism Involved in Lipid-Lowering Therapy

The treatment of hypercholesterolemia is mainly based on statins. However, the response to pharmacological therapy shows high inter-individual variability, resulting in variable effects in both lipid lowering and risk reduction. Thus, a better understanding of the lipid-lowering mechanisms and respo...

Full description

Bibliographic Details
Main Authors: Leal, K. (Author), Paez, I. (Author), Prado, Y. (Author), Rojas, G. (Author), Saavedra, K. (Author), Saavedra, N. (Author), Salazar, L.A (Author), Ubilla, C.G (Author)
Format: Article
Language:English
Published: MDPI 2022
Subjects:
atorvastatin
cardiovascular diseases
hypercholesterolemia
microRNA
statin
Online Access:View Fulltext in Publisher

Similar Items

Similar Items